Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and quinoline

quinazolines has been researched along with quinoline in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's6 (54.55)24.3611
2020's4 (36.36)2.80

Authors

AuthorsStudies
Chen, Y; Hano, Y; Ma, Z; Nomura, T1
Cao, R; Mi, N; Zhang, H1
Nevalainen, T; Saari, R; Törmä, JC1
Bak-Sypien, II; Dominska, K; Galdyszynska, M; Karwowski, BT; Merecz-Sadowska, A; Piastowska-Ciesielska, AW; Stanczak, A; Szumilak, M1
Arrowsmith, CH; Babault, N; Brown, PJ; Chen, X; Dong, A; Jin, J; Li, F; Liu, J; Vedadi, M; Wu, H; Xiong, Y; Zeng, H1
Goto, M; Guo, X; Lee, KH; Li, JC; Liu, YQ; Morris-Natschke, SL; Shang, XF; Xu, XS; Yang, GZ1
Goto, M; Guo, X; Lee, KH; Li, JC; Liu, YQ; Morris-Natschke, SL; Shang, XF; Xu, XS; Yang, GZ; Zhang, JY1
Esmaeili, S; Fassihi, A; Fayyazi, N; Ghasemi, JB; Saghaie, L; Taheri, S1
Charles, MRC; Coumar, MS; Dhayalan, A; Hsieh, HP; Lin, SY; Mahesh, A1
Damodar, K; Gim, JG; Jeon, SH; Lee, JT; Lee, Y; Nam, KY; Park, JP; Park, LS1
Astolfi, A; Barreca, ML; Biavasco, F; Cannalire, R; Cecchetti, V; Cedraro, N; Cernicchi, G; Felicetti, T; Manfroni, G; Mangiaterra, G; Massari, S; Sabatini, S; Tabarrini, O; Vaiasicca, S1

Reviews

2 review(s) available for quinazolines and quinoline

ArticleYear
Biologically active quinoline and quinazoline alkaloids part I.
    Medicinal research reviews, 2018, Volume: 38, Issue:3

    Topics: Alkaloids; Animals; Humans; Immunologic Factors; Protective Agents; Quinazolines; Quinolines

2018
Biologically active quinoline and quinazoline alkaloids part II.
    Medicinal research reviews, 2018, Volume: 38, Issue:5

    Topics: Alkaloids; Anti-Inflammatory Agents; Antioxidants; Humans; Protective Agents; Quinazolines; Quinolines

2018

Other Studies

9 other study(ies) available for quinazolines and quinoline

ArticleYear
Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities.
    Bioorganic & medicinal chemistry letters, 2004, Mar-08, Volume: 14, Issue:5

    Topics: Alkaloids; Animals; Cell Line, Tumor; DNA Topoisomerases, Type II; Enzyme Inhibitors; Mice; Quinazolines; Quinolines; Topoisomerase II Inhibitors

2004
3D-QSAR study of c-Src kinase inhibitors based on docking.
    Journal of molecular modeling, 2010, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Computer Simulation; CSK Tyrosine-Protein Kinase; Humans; Nitriles; Protein Binding; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quantitative Structure-Activity Relationship; Quinazolines; Quinolines; src-Family Kinases

2010
Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists.
    Bioorganic & medicinal chemistry, 2011, Jan-15, Volume: 19, Issue:2

    Topics: Isoquinolines; Microwaves; Morpholines; Quinazolines; Quinolines; Quinoxalines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2011
Synthesis, Biological Activity and Preliminary in Silico ADMET Screening of Polyamine Conjugates with Bicyclic Systems.
    Molecules (Basel, Switzerland), 2017, May-12, Volume: 22, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA; DNA Topoisomerases, Type I; Drug Design; Escherichia coli; Humans; Indoles; Naphthalenes; Nucleic Acid Conformation; Polyamines; Quinazolines; Quinolines; Rats; Structure-Activity Relationship

2017
Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.
    Bioorganic & medicinal chemistry, 2017, 08-15, Volume: 25, Issue:16

    Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Models, Molecular; Molecular Structure; Quinazolines; Quinolines; Structure-Activity Relationship

2017
Molecular dynamics simulation and 3D-pharmacophore analysis of new quinoline-based analogues with dual potential against EGFR and VEGFR-2.
    International journal of biological macromolecules, 2020, Jan-01, Volume: 142

    Topics: A549 Cells; Aminoquinolines; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Piperidines; Protein Conformation; Quinazolines; Quinolines; Sorafenib; Vascular Endothelial Growth Factor Receptor-2

2020
Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening.
    Biochimie, 2020, Volume: 168

    Topics: Azepines; Catalytic Domain; Databases, Chemical; Enzyme Inhibitors; HEK293 Cells; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Protein Binding; Quinazolines; Quinolines

2020
Design and Synthesis of π-Extended Resveratrol Analogues and In Vitro Antioxidant and Anti-Inflammatory Activity Evaluation.
    Molecules (Basel, Switzerland), 2021, Jan-26, Volume: 26, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Survival; Gene Expression Regulation; Interleukin-1beta; Interleukin-6; Isoquinolines; Lipopolysaccharides; Mice; Naphthalenes; Quinazolines; Quinolines; Quinoxalines; RAW 264.7 Cells; Resveratrol; Stilbestrols; Structure-Activity Relationship

2021
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search.
    ChemMedChem, 2021, 10-06, Volume: 16, Issue:19

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Quinolines; Structure-Activity Relationship

2021